Skip to main content
Premium Trial:

Request an Annual Quote

Jerini Peptide Technologies Wins Slot in Virginia Biotech Incubator

NEW YORK, Oct. 26 (GenomeWeb News) - Jerini Peptide Technologies, a wholly-owned subsidiary of Berlin-based pharmaceutical company Jerini, will establish its first US operations at the Farifax County BioAccelerator business incubator in Virginia, the company said yesterday.

 

Jerini Peptide Technologies manufactures and markets tools and arrays made from synthetic peptides for use in biomedical research and drug discovery.

 

JPT said it gained the right to enter the BioAccelerator after edging out eight German biotechnology companies in a 2003 Farifax County Economic Development Authority business plan competition.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.